These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 34209023)

  • 1. Nanocarriers for Biomedicine: From Lipid Formulations to Inorganic and Hybrid Nanoparticles.
    Kashapov R; Ibragimova A; Pavlov R; Gabdrakhmanov D; Kashapova N; Burilova E; Zakharova L; Sinyashin O
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility.
    Tarn D; Ashley CE; Xue M; Carnes EC; Zink JI; Brinker CJ
    Acc Chem Res; 2013 Mar; 46(3):792-801. PubMed ID: 23387478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in liposomal nanohybrid cerasomes as promising drug nanocarriers.
    Yue X; Dai Z
    Adv Colloid Interface Sci; 2014 May; 207():32-42. PubMed ID: 24368133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified magnetic core-shell mesoporous silica nano-formulations with encapsulated quercetin exhibit anti-amyloid and antioxidant activity.
    Halevas E; Mavroidi B; Nday CM; Tang J; Smith GC; Boukos N; Litsardakis G; Pelecanou M; Salifoglou A
    J Inorg Biochem; 2020 Dec; 213():111271. PubMed ID: 33069945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesoporous Silica Molecular Sieve based Nanocarriers: Transpiring Drug Dissolution Research.
    Pattnaik S; Pathak K
    Curr Pharm Des; 2017; 23(3):467-480. PubMed ID: 27784249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of surface modification and size on oral drug delivery of mesoporous silica formulation.
    Wang Y; Cui Y; Zhao Y; Zhao Q; He B; Zhang Q; Wang S
    J Colloid Interface Sci; 2018 Mar; 513():736-747. PubMed ID: 29220688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-Assembling Drug Formulations with Tunable Permeability and Biodegradability.
    Gaynanova G; Vasileva L; Kashapov R; Kuznetsova D; Kushnazarova R; Tyryshkina A; Vasilieva E; Petrov K; Zakharova L; Sinyashin O
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34833877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid, protein and poly(NIPAM) coated mesoporous silica nanoparticles for biomedical applications.
    Yang Y; Li J
    Adv Colloid Interface Sci; 2014 May; 207():155-63. PubMed ID: 24268194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers.
    Wang Y; Zhao Y; Cui Y; Zhao Q; Zhang Q; Musetti S; Kinghorn KA; Wang S
    Acta Biomater; 2018 Jan; 65():405-416. PubMed ID: 29037897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators.
    Yang Y; Zhang M; Song H; Yu C
    Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-based nanocarriers for enhanced delivery of plant-derived bioactive molecules: a comprehensive review.
    Kothapalli P; Vasanthan M
    Ther Deliv; 2024 Feb; 15(2):135-155. PubMed ID: 38214118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
    Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
    Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid mesoporous silica nanospheres modified by poly (NIPAM-co-AA) for drug delivery.
    Zhang K; Zhou D; Wang Z; Zhang Y; He P
    Nanotechnology; 2019 Aug; 30(35):355604. PubMed ID: 31071691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in porous nanoparticles for drug delivery in antitumoral applications: inorganic nanoparticles and nanoscale metal-organic frameworks.
    Baeza A; Ruiz-Molina D; Vallet-Regí M
    Expert Opin Drug Deliv; 2017 Jun; 14(6):783-796. PubMed ID: 27575454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of mesoporous silica nanoparticles for oral drug delivery - current status and perspective of MSNs drug carriers.
    Florek J; Caillard R; Kleitz F
    Nanoscale; 2017 Oct; 9(40):15252-15277. PubMed ID: 28984885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesoporous Silica Nanoparticles: Drug Delivery Vehicles for Antidiabetic Molecules.
    Sarkar S; Ekbal Kabir M; Kalita J; Manna P
    Chembiochem; 2023 Apr; 24(7):e202200672. PubMed ID: 36719179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
    Gupta A; Kushwaha SS; Mishra A
    Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery.
    Giret S; Wong Chi Man M; Carcel C
    Chemistry; 2015 Sep; 21(40):13850-65. PubMed ID: 26250991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosafety of mesoporous silica nanoparticles; towards clinical translation.
    Lérida-Viso A; Estepa-Fernández A; García-Fernández A; Martí-Centelles V; Martínez-Máñez R
    Adv Drug Deliv Rev; 2023 Oct; 201():115049. PubMed ID: 37573951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optically active organic and inorganic nanomaterials for biological imaging applications: A review.
    Sowmiya P; Dhas TS; Inbakandan D; Anandakumar N; Nalini S; Suganya KSU; Remya RR; Karthick V; Kumar CMV
    Micron; 2023 Sep; 172():103486. PubMed ID: 37262930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.